Resources Clinical studies Carmelina Cardiovascular Results - No HHF Carmelina Cardiovascular Results Carmelina Kidney Results - Lower Risk Of Albuminurea Carmelina Kidney Results Safety Trajenta Simplicity of Dosing Trajenta Simplicity Trajenta Efficacy vs Trajenta Efficacy Regardless of Age Trajenta Efficacy With Same Dose In Severe Renal Impairment Trajenta Efficacy With Same Dose Regardless of Kidney Function Carmelina Study Design Carmelina Study Inclusion Criteria Carmelina Trial Overview Trajenta Efficacy up to 104 Weeks vs Glimepride Trajenta Efficacy Added To Metformin Trajenta Efficacy Regardless of BMI Trajenta Efficacy vs Pioglitazone EMPA-REG OUTCOME Trial Results Efficacy Superiority Over SU Main Benefits Dosing Jardiance® SmPC Synjardy® SmPC EMPA-REG OUTCOME Study Design How does Nintedanib benefit patients in preserving lung function? How does dosing and administration of Nintedanib help compliance of IPF patients? Is honeycombing in an HRCT, the sole detector of IPF? Prescribing Information 02:10 How to recognize Stroke? Actilyse Dosing 2 Symptoms of Stroke Treatment of Stroke Load more
